Organ and Tissue Transplantation: A Global Strategic Business Report
San Jose, California (PRWEB) February 23, 2012
Follow us on LinkedIn – Buoyed by advancements in technology, surgical techniques and immunosuppressive drugs, organ transplantation has become the preferred treatment for several chronic diseases pertaining to heart, kidneys, lungs, pancreas, and liver. Advancements in organ and tissue transplantation have phenomenally revolutionized the quality of life and survival rate across terminal conditions. While a tissue transfer enhances the quality of life of a patient, organ transfer saves or enhances the lives of patients suffering from organ failures. Organ transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end-stage diseases. Several policies guide transplantations around the world, and there exists various possibilities to procure as well as allocate organs for transplantation. On the flip side, although transplantation is considered as the last alternative to save a person suffering from organ failure, the limited supply of organs coupled with the economic crisis, and huge expenses associated with the transplant surgery inhibited transplantation procedures over the recent years. Recession resulted in a significant decline in those seeking organ transplants in 2008, specifically in the Western countries.
Dearth of organs has been adversely affecting the number of transplant procedures, as several patients suffering from chronic illnesses and waiting for organ transplants die without the receipt of a suitable organ. This, in turn, is fueling the black market for organs, as well as propelling the medical tourism market, which is driving people overseas to buy organs for transplantations. A major reform is the need of the hour in the existing organ donation and transplant system, to spur organ transplantation procedures, and reduce mortality rate arising due to organ shortage, and in turn, the timely transplant.
The escalating imbalance between the supply and demand can also be effectively addressed through increasing awareness programs and educating people about the need and importance of organ donation. The education is being aimed at eliminating misconceptions and fear of organ donations, and attitudinal change of organ donation as a social responsibility, especially after-life organ donation. Educating the family members and relatives of the deceased persons is also expected to increase the deceased organ donations. Further, state governments and organ procurement organizations are working in tandem and conducting awareness programs to increase organ donations.
Europe represents the leading region, accounting for a major share of the total organ transplant procedures, as stated by the new market research report on Organ and Tissue Transplantation. The US trails behind Europe, in terms of number of organ transplantations conducted. However, Asia is expected to witness fastest growth in terms of transplant procedures, advancing ahead at a compounded annual rate of more than 6.0% during the analysis period. Kidney transplants, by far, is the largest and fastest growing segment in terms of procedure volume. The segment is expected to register a CAGR of more than 3.0% over the analysis period. Liver transplants represents the second fastest growing segment in procedure volume across the world. Number of liver transplants is projected to record a compounded annual growth of more than 3.0% during the analysis period.
Major players profiled in the report include Abiomed Inc., CryoLife Inc., Exactech Inc., Fresenius Medical Care AG & Co. KgaA, Gambro AB, Genzyme Corp., Jarvik Heart Inc., LifeCell Corporation, Medtronic Inc., MicroMed Cardiovascular Inc., Organogenesis Inc., SynCardia Systems, Terumo Corporation, Teleflex Inc., Thoratec Corporation, WorldHeart Corporation, among others.
The research report titled “Organ and Tissue Transplantation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the Organ and Tissue Transplantation, impact of the recession on the market, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual number of organ transplantation procedures for the years 2009 through 2017 for the following geographic markets - US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Key organ transplantations analyzed include Heart, Kidney, Liver, Pancreas, Lung, and Intestine Transplants. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/